Dyne Therapeutics Inc — Cash Flow (NASDAQ:DYN) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -46.51 M-119.56 M-153.65 M-188.16 M-292.37 M-403.21 M -403.21 M Cash from investing activities -45.66 M-137.89 M87.2 M83.31 M-204.08 M-28.75 M -28.75 M Cash from financing activities 380.69 M157.82 M37.39 M54.32 M809.89 M890.31 M 890.31 M Free cash flow -47.67 M-123.18 M-156.71 M-188.89 M-294.75 M-405.13 M -405.13 M

뉴스

Jefferies reiterates Buy on BioMarin stock after DMD trial data

Micron and Palantir among market cap stock movers on Tuesday

Dyne Therapeutics, Inc. (DYN) Presents at TD Cowen 46th Annual Health Care Conference Prepared Remarks Transcript

Dyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case (NASDAQ:DYN)

바 Baird, Dyne Therapeutics ’매수’ 등급 재확인

Baird reiterates Dyne Therapeutics stock rating on trial progress

Jones Trading, Dyne Therapeutics ’매수’ 의견 재확인

Jones Trading reiterates Buy on Dyne Therapeutics stock after DMD, DM1 updates

다인 테라퓨틱스, 임상 설계에 Stifel의 ’매수’ 의견 재확인

Stifel reiterates Dyne Therapeutics stock rating on trial design

Dyne, 근이영양증 데이터 발표 후 전망 개선 - Jones

Dyne stock looks stronger after muscular dystrophy data, says Jones